Advertisement
Detectable levels of glyphosate

Detectable Levels of Roundup Ingredient Rising in Older Adults

0
Urinary excretion rates of glyphosate, AMPA increased from 1993-1996 to 2014-2016
Hypothermia treatment initiated at six to 24 hours after birth for newborns with hypoxic-ischemic encephalopathy may reduce death or disability

Hypothermia May Help Newborns With Encephalopathy

0
Appears to reduce death, disability in infants with encephalopathy, but effectiveness uncertain
Patients with multiple sclerosis have peripheral nerve involvement that can be visualized and quantified by high-resolution magnetic resonance neurography

MRN Helps Quantify Peripheral Nerve Involvement in MS

0
High-resolution magnetic resonance neurography detected lesions in all multiple sclerosis patients examined
Results of the Physicians Foundation 2017 Patient Survey show that most patients are satisfied with their overall relationship with their physician

Most Patients Satisfied With Relationship With Physician

0
But majority of patients, physicians think doctors don't have time to provide highest standard of care

September 2017 Briefing – Neurology

0
Here are what the editors at HealthDay consider to be the most important developments in Neurology for September 2017. This roundup includes the latest...
OnabotulinumtoxinA injections are beneficial for pediatric patients with chronic migraine

ASA: Botox Injections Beneficial for Migraine in Children

0
Statistically significant changes in migraine intensity, frequency, duration from pre- to post-therapy
The public is being given its 14th opportunity to safely dispose of pills and patches at collection points operated by the U.S. Drug Enforcement Agency and its partners.

DEA Taking Back Unwanted Prescription Drugs on Oct. 28

0
Only pills or patches will be accepted, not liquids, needles, or sharps; service is free and anonymous
For patients with progressive multifocal leukoencephalopathy

Caution for PLEX in Progressive Multifocal Leukoencephalopathy

0
Plasma exchange not linked to PML immune reconstitution inflammatory syndrome latency
Sub-anesthetic ketamine infusions are associated with improved short-term pain relief for migraine and other intractable headache

ASA: Ketamine Infusions May Relieve Pain in Migraine

0
Least pain on day 4, achieved at mean ketamine rates of 30.8±3.6 mg/hr less than maximum dose
The strongest evidence for benefit of cannabinoids in children is for chemotherapy-induced nausea and vomiting

Limited Evidence of Benefit for Medical Cannabinoids in Children

0
Strongest evidence for benefit in chemo-induced nausea, vomiting; other uses need more evidence